LB PHARMACEUTICALS INC (LBRX) Form 424B3 — Jul 29, 2026
LB Pharmaceuticals Inc. announced a private placement financing involving the sale of common stock and pre-funded warrants. The company agreed to sell 3,577,560 shares of common stock and pre-funded warrants to purchase 715,513 shares at a purchase price of $34.94 per share. The deal is expected to generate gross proceeds of approximately $150.0 million before expenses.
Key figures
- Gross Proceeds
- 150000000
- Offering Price
- 34.94
- Common shares sold
- 3577560
- Warrant exercise price
- 0.0001
- Pre funded warrant shares
- 715513
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.